NEW DELHI: With the Indian rupee crossing the 80 level against the US dollar, experts say the changing dynamics in the forex market can be a tailwind for stock investors in a turbulent market if their portfolios are positioned accordingly.…
A host of brokerages have come out with reports, offering insights into how various sectors performed in the June quarter and what investors should expect going into the results season. While a few sectors are yet to be previewed by…
Cipla Health’s multivitamin supplement brand Maxirich in association with Taproot Dentsu has launched a new television commercial featuring its brand ambassador Ayushmann Khurrana. Through the campaign, the brand aims to create awareness…
Dr Jaideep A Gogtay, Global Chief Medical Officer at Cipla, one of India’s leading pharma companies with a long history and some incredible firsts in the generics space and solutions that have greatly enhanced access to some of the critical…
Markets at Lunch (01:30 PM) LIVE market updates: The bears continued to dominate proceedings on the Dalal Street with key benchmark indices deep in red. However, fresh…
NEW DELHI: shone like a beacon on a cold dark night on Dalal Street. The stock spiked 14 per cent on Monday during the day while the entire market was in shambles.
The stock jumped after the company on Friday reported a two-fold jump in…
“FY23 should look largely normal again on a YoY deflation basis. This year, we have seen price deflations hoving around the high single digits – 8-9%. I hope that it will come down to the normal 4-5% level starting FY23,” says Nithya…
Indian giants Sun Pharmaceutical Industries, Optimus Pharma, and Dr Reddy’s Laboratories are exploring the possibility of manufacturing the pill, reports suggest.
On Wednesday, Pfizer received the US Food & Drug Administration’s…